Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2

被引：0
|
作者：
SM Johnson
JA Shaw
RA Walker
机构：
[1] University of Leicester,Breast Cancer Research Unit
[2] Clinical Sciences,undefined
[3] Glenfield Hospital,undefined
来源：
Breast Cancer Research | / 2卷 / Suppl 1期
关键词：
Breast Cancer; Paraffin; Young Woman; Pathological Feature; Full Text;
D O I：
10.1186/bcr96
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia
    Troudi, Wafa
    Uhrhammer, N.
    Sibille, C.
    Dahan, C.
    Mahfoudh, W.
    Souissi, C. Bouchlaka
    Jalabert, T.
    Chouchane, L.
    Bignon, Y. J.
    Ben Ayed, F.
    Elgaaied, A. Ben Ammar
    JOURNAL OF HUMAN GENETICS, 2007, 52 (11) : 915 - 920
  • [32] High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
    Fackenthal, James D.
    Zhang, Jing
    Zhang, Bifeng
    Zheng, Yonglan
    Hagos, Fitsum
    Burrill, Devin R.
    Niu, Qun
    Huo, Dezheng
    Sveen, Walmy E.
    Ogundiran, Temidayo
    Adebamowo, Clemet
    Odetunde, Abayomi
    Falusi, Adeyinka G.
    Olopade, Olufunmilayo I.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : 1114 - 1123
  • [33] Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
    Porcu, Eleonora
    Cillo, Giulia Maria
    Cipriani, Linda
    Sacilotto, Federica
    Notarangelo, Leonardo
    Damiano, Giuseppe
    Dirodi, Maria
    Roncarati, Ilaria
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (03) : 709 - 715
  • [34] Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing
    Cappelli, M
    Surh, L
    Humphreys, L
    Verma, S
    Logan, D
    Hunter, A
    Allanson, J
    QUALITY OF LIFE RESEARCH, 2001, 10 (07) : 595 - 607
  • [35] Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
    Eleonora Porcu
    Giulia Maria Cillo
    Linda Cipriani
    Federica Sacilotto
    Leonardo Notarangelo
    Giuseppe Damiano
    Maria Dirodi
    Ilaria Roncarati
    Journal of Assisted Reproduction and Genetics, 2020, 37 : 709 - 715
  • [36] Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing
    M. Cappelli
    L. Surh
    L. Humphreys
    S. Verma
    D. Logan
    A. Hunter
    J. Allanson
    Quality of Life Research, 2001, 10 : 595 - 607
  • [37] Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia
    Wafa Troudi
    N. Uhrhammer
    C. Sibille
    C. Dahan
    W. Mahfoudh
    C. Bouchlaka Souissi
    T. Jalabert
    L. Chouchane
    Y. J. Bignon
    F. Ben Ayed
    A. Ben Ammar Elgaaied
    Journal of Human Genetics, 2007, 52 : 915 - 920
  • [38] Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women
    Loizzi, Vera
    Cerbone, Marco
    Arezzo, Francesca
    Silvestris, Erica
    Damiani, Gianluca Raffaello
    Cazzato, Gerardo
    Cicinelli, Ettore
    Cormio, Gennaro
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 23 (02): : 277 - 286
  • [39] Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations
    Kim, Daniel H.
    Crawford, Beth
    Ziegler, John
    Beattie, Mary S.
    FAMILIAL CANCER, 2009, 8 (02) : 153 - 158
  • [40] Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellin, Colombia
    Londono Hernandez, Julian Esteban
    Llacuachaqui, Marcia
    Vasquez Palacio, Gonzalo
    David Figueroa, Juan
    Madrid, Jorge
    Lema, Mauricio
    Royer, Robert
    Li, Song
    Larson, Garrett
    Weitzel, Jeffrey N.
    Narod, Steven A.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2014, 12
12345